NCT02788981: A Trial of Nanoparticle Albumin-Bound Paclitaxel (Nab-Paclitaxel), Abraxane With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

Breast Cancer Type: Triple Negative
Hormone Mutations: GR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 2
Drug Category: Endocrine (Hormone Therapy, Chemotherapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult), Senior)
Location of Metastases: 
Additional Notes: Tumor must also be GR+
Exclusions: Patients with known brain metastases will be eligible, but conditions apply- see trial for details

Up ↑